RATA: A novel class A carbapenemase with broad geographic distribution and potential for global spread

  09 May 2024

Carbapenem resistance is a global health issue, primarily due to carbapenemase production. A new carbapenemase, RATA, was discovered in Riemerella anatipestifer isolates, which shares a 52% amino acid sequence identity with other β-lactamases. RATA hydrolyzes penicillins, cephalosporins, monobactams, cephamycins, and carbapenems and can be inhibited by β-lactamase inhibitors. Bioinformatic analysis revealed 46 blaRATA-like genes encoding 27 variants, primarily from marine environments. blaRATA orthologue genes were found on Flavobacteriaceae chromosomes, sharing similar GC content. The study suggests RATA is a new chromosome-encoded class A carbapenemase.

Author(s): Hongyan Luo et al
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed